BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36805440)

  • 1. Identification of G protein subunit alpha i2 as a promising therapeutic target of hepatocellular carcinoma.
    Chen M; Li Z; Gu C; Zheng H; Chen Y; Cheng L
    Cell Death Dis; 2023 Feb; 14(2):143. PubMed ID: 36805440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein inhibitory α subunit 2 is a molecular oncotarget of human glioma.
    Wang Y; Liu F; Wu J; Zhang MQ; Chai JL; Cao C
    Int J Biol Sci; 2023; 19(3):865-879. PubMed ID: 36778118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
    Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
    Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein subunit alpha i2's pivotal role in angiogenesis.
    Bai CW; Lu L; Zhang JN; Zhou C; Ni YC; Li KR; Yao J; Zhou XZ; Lan CG; Cao C
    Theranostics; 2024; 14(5):2190-2209. PubMed ID: 38505600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBO1 overexpression is important for hepatocellular carcinoma cell growth.
    Zhong W; Liu H; Deng L; Chen G; Liu Y
    Cell Death Dis; 2021 May; 12(6):549. PubMed ID: 34039960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lncRNA
    Zhou N; Li S; Wu D; Zhang F; Tang F; Li Y
    DNA Cell Biol; 2021 Oct; 40(10):1278-1289. PubMed ID: 34558987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
    Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
    PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.
    Yao J; Liang L; Huang S; Ding J; Tan N; Zhao Y; Yan M; Ge C; Zhang Z; Chen T; Wan D; Yao M; Li J; Gu J; He X
    Hepatology; 2010 Mar; 51(3):846-56. PubMed ID: 20054866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma.
    Xiang Q; Zhou D; He X; Fan J; Tang J; Qiu Z; Zhang Y; Qiu J; Xu Y; Lai G
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2196-2205. PubMed ID: 30995348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
    Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
    Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis.
    Zhang Z; Zhao Q; Wang Z; Xu F; Liu Y; Guo Y; Li C; Liu T; Zhao Y; Tang X; Zhang J
    Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38437062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.
    Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L
    J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling.
    Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF
    J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
    Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
    Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma.
    Wang W; Jia WD; Hu B; Pan YY
    Oncotarget; 2017 Apr; 8(16):26434-26447. PubMed ID: 28460436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.